Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RLB vs ESPB for Multiple Rib Fractures
NCT06088836Completed
- Sponsor
- Tanta University
- Start
- Oct 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bupivacaine in pain (2 arms), sponsored by Tanta University. Primary endpoint: Maximum inspired volume at 4 days. Started Oct 2023; status: completed.
02
Drugs
bupivacaine
03
Conditions
pain
Beyond the preview
Go deeper on NCT06088836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06088836.